VascVersa
Latest round
- Seed
Last raised
- May 2022
Total raised
- $0.6M
Investors
- 3
About VascVersa
Based in Belfast, Ireland, and founded in 2018 by Dr. Christina O’Neill (CEO), VascVersa Ltd provides early-stage regenerative medicine to patients. The company offers cell therapy products as a new treatment for vascular regeneration. It provides ANGICYTE™ technology that can develop new cell therapies to treat diseases by regenerating tissue and this act as the forefront of medicine.
Who invested in VascVersa
3 investors across 1 round
See all investors in VascVersa
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 3, 2022
Amount
$0.6M
Investors
Questions about VascVersa
Who invested in VascVersa?
VascVersa has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VascVersa raised?
VascVersa has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did VascVersa last raise money?
VascVersa's most recent round on record is a Seed, in May 2022.
What does VascVersa do?
Based in Belfast, Ireland, and founded in 2018 by Dr.
Where is VascVersa headquartered?
VascVersa is headquartered in Belfast, Ireland.
Which VCs invest in companies like VascVersa?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at VascVersa's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like VascVersa? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.